Effect of ischemic preconditioning in skeletal muscle measured by functional magnetic resonance imaging and spectroscopy: A randomized crossover trial

Background: nuclear magnetic resonance (nmr) imaging and spectroscopy have been applied to assess skeletal muscle oxidative metabolism. therefore,in-vivo nmr may enable the characterization of ischemia-reperfusion injury. the goal of this study was to evaluate whether nmr could detect the effects of ischemic preconditioning (ipc) in healthy subjects. methods. twenty-three participants were included in two randomized crossover protocols in which the effects of ipc were measured by nmr and muscle force assessments. leg ischemia was administered for 20 minutes with or without a subsequent impaired reperfusion for 5 minutes (stenosis model). ipc was administered 4 or 48 hours prior to ischemia. changes in 31phosphate nmr spectroscopy and blood oxygen level-dependent (bold) signals were recorded. 3-tesla nmr data were compared to those obtained for isometric muscular strength. results: the phosphocreatine (pcr) signal decreased robustly during ischemia and recovered rapidly during reperfusion. in contrast to pcr,the recovery of muscular strength was slow. during post-ischemic stenosis,pcr increased only slightly. the bold signal intensity decreased during ischemia,ischemic exercise and post-ischemic stenosis but increased during hyperemic reperfusion. ipc 4 hours prior to ischemia significantly increased the maximal pcr reperfusion signal and mitigated the peak bold signal during reperfusion. conclusions: ischemic preconditioning positively influenced muscle metabolism during reperfusion; this resulted in an increase in pcr production and higher oxygen consumption,thereby mitigating the peak bold signal. in addition,an impairment of energy replenishment during the low-flow reperfusion was detected in this model. thus,functional nmr is capable of characterizing changes in reperfusion and in therapeutic interventions in vivo. trial registration. clinicaltrials.gov: nct00883467. © 2011 andreas et al; licensee biomed central ltd.